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ImmunoRatio: a publicly available web
application for quantitative image analysis of
estrogen receptor (ER), progesterone receptor
(PR), and Ki-67
Vilppu J Tuominen1, Sanna Ruotoistenmäki1,2, Arttu Viitanen1, Mervi Jumppanen2, Jorma Isola1*
Abstract
Introduction: Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 is essential in
the histopathologic diagnostics of breast cancer. Commercially available image analysis systems are usually
bundled with dedicated analysis hardware and, to our knowledge, no easily installable, free software for
immunostained slide scoring has been described. In this study, we describe a free, Internet-based web application
for quantitative image analysis of ER, PR, and Ki-67 immunohistochemistry in breast cancer tissue sections.
Methods: The application, named ImmunoRatio, calculates the percentage of positively stained nuclear area
(labeling index) by using a color deconvolution algorithm for separating the staining components
(diaminobenzidine and hematoxylin) and adaptive thresholding for nuclear area segmentation. ImmunoRatio was
calibrated using cell counts defined visually as the gold standard (training set, n = 50). Validation was done using a
separate set of 50 ER, PR, and Ki-67 stained slides (test set, n = 50). In addition, Ki-67 labeling indexes determined
by ImmunoRatio were studied for their prognostic value in a retrospective cohort of 123 breast cancer patients.
Results: The labeling indexes by calibrated ImmunoRatio analyses correlated well with those defined visually in the
test set (correlation coefficient r = 0.98). Using the median Ki-67 labeling index (20%) as a cutoff, a hazard ratio of
2.2 was obtained in the survival analysis (n = 123, P = 0.01). ImmunoRatio was shown to adapt to various staining
protocols, microscope setups, digital camera models, and image acquisition settings. The application can be used
directly with web browsers running on modern operating systems (e.g., Microsoft Windows, Linux distributions,
and Mac OS). No software downloads or installations are required. ImmunoRatio is open source software, and the
web application is publicly accessible on our website.
Conclusions: We anticipate that free web applications, such as ImmunoRatio, will make the quantitative image
analysis of ER, PR, and Ki-67 easy and straightforward in the diagnostic assessment of breast cancer specimens.
Introduction
Immunohistochemical staining of the estrogen receptor
(ER), progesterone receptor (PR), and proliferation anti-
gen Ki-67 are routinely used in the diagnostic assess-
ment of breast cancer. Positive ER status of a tumor is
considered necessary for patients to be eligible for post-
surgical hormonal therapies. ER and PR assays are based
on immunohistochemistry performed on formalin-fixed
and paraffin-embedded tumor tissue blocks [1].
Although the analytical quality of ER and PR assays has
been debated for decades, recent results of interlabora-
tory quality assurance studies provide convincing evi-
dence for the high reproducibility of these laboratory
staining procedures [2,3]. The tumor cell proliferation
antigen level, as defined by Ki-67 immunostaining, is an
auxiliary tool for defining patient prognosis. Patients
with rapidly proliferating tumors are predicted to endure
poorer outcomes than patients with tumors exhibiting
low proliferation [4]. Meta-analyses confirming the role
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of Ki-67 as a prognostic factor have included more than
15,000 patients [5].
Common practice in pathology laboratories is to score
ER-, PR-, and Ki-67-stained slides visually (also termed
manually) using light microscopy at medium power
magnification (10× or 20× objectives). For ER and PR
evaluation, a tumor is scored as negative or positive or,
as is currently recommended, by evaluating the percen-
tage of positively stained tumor cell nuclei [6]. A thresh-
old of 10% total stained tumor cells is commonly used
as a cut-off for defining positive ER and PR status. A
combination of the stained cell percentage and the
staining intensity is applied in histoscore and Allred-
score methods [7,8]. Whichever scoring method is used,
it is well known that microscopic evaluation of ER- and
PR-stained slides is subjective and can lead to significant
inter-observer variability. For example, in an extensive
inter-laboratory study of 172 pathologists, 24% of ER-
positive slides were interpreted as falsely negative [9].
Interpretation of Ki-67 staining can be even more diffi-
cult, mainly owing to the lack of uniformly accepted
cut-off points for defining low- and high-risk patient
groups. In most of the published studies included in the
meta-analyses, Ki-67 has been evaluated in a single cen-
ter or by one or very few observers, thereby failing to
address the problem of possible inter-observer variability
[4,5]. The magnitude of inter-observer variability for Ki-
67 scoring is largely unknown, but there is no reason to
believe that it would be less than that of ER and PR.
In clinical practice, ER-, PR- and Ki-67-stained slides
are interpreted by a pathologist. Careful estimation of
the percentage of positively stained cells (labeling index)
is not only prone to inter-observer variation, but is also
tedious and time-consuming. To overcome this, various
digital image analysis methods have been described
[10,11]. The principles behind quantitative immunohis-
tochemistry analyses are based on differentiation of the
staining components by using, for example, the color
deconvolution algorithm [12]. The color deconvolution
algorithm detects and separates multiple stains by ana-
lyzing their absorption spectra and relative contributions
to areas containing two or more overlapping stains.
Although the optical density of the immunoreaction
product (brown diaminobenzidine (DAB) precipitate)
may not accurately reflect the abundance of the antigen
(ER, PR, or Ki-67 protein), systems discriminating
between negatively and positively stained cells have
turned out to be useful [13]. Unfortunately, the image
analysis software described in the literature is seldom
released for public use. Likewise, the commercially avail-
able software is usually proprietary and/or bundled with
dedicated analysis equipment or virtual microscopy
scanners, making it difficult to compare them [14].
In order to become widely accepted and utilized by
pathologists, a digital image analysis system should be
easily accessible, not require dedicated equipment or
software installation, and be compatible with existing
microscope setups. For this purpose, we developed an
image analysis application, named ImmunoRatio, which
is accessed and used within a web browser. ImmunoRa-
tio supports all modern web browsers and operating sys-
tems, requiring no software installation. The application
segments immunostained and hematoxylin-stained cellu-
lar areas from the user-submitted image and calculates
the labeling index (percent of DAB-stained area out of
the total nuclear area). ImmunoRatio is free, open
source, and publicly available on our research group
website [15].
Materials and methods
Immunohistochemistry
Formalin-fixed and paraffin-embedded tissue sections
from invasive breast cancers were derived from the
archive of the Department of Pathology, Seinäjoki Cen-
tral Hospital. The study has been approved by the
Scientific Committee of Seinäjoki Central Hospital, Fin-
land. According to the Finnish national ethics commit-
tee regulations, informed consent was not considered
necessary for this study. Immunohistochemical stainings
of ER, PR, and Ki-67 tissue sections followed the recom-
mended staining protocols [3]. The slides were stained
using the BondMax staining robot (Leica Microsystems,
Wetzlar, Germany). In brief, ER was detected using
monoclonal antibody 6F11 (diluted 1:300, Leica Biosys-
tems, Newcastle, UK), PR was detected using monoclo-
nal antibody PgR636 (diluted 1:600, Leica Biosystems,
Newcastle, UK), and Ki-67 was detected using monoclo-
nal antibody MIB-1 (diluted 1:100, Dako, Carpinteria,
CA, USA). Antigen retrieval was performed in Tris-
EDTA buffer (pH 9, 100°C for 40 minutes). Bound anti-
bodies were visualized using Bond Refine Detection kit
(Leica Biosystems, Newcastle, UK). Immunoreaction was
intensified using 0.5% copper sulfate (5 minutes). Hema-
toxylin counterstaining (1 minutes in ChemMate diluted
1:6, Dako, Carpinteria, CA, USA) was performed using
PBS as bluing reagent. The samples were cleared with
ethanol and xylene and mounted using standard
procedures.
Prognostic validation
Samples from 123 primary breast cancer patients were
derived from the archives of the Department of Pathol-
ogy at Tampere University Hospital, with the permission
from National Supervisory Authority for Welfare and
Health (Köninki et al.: Analysis of PIK3CA mutations
and protein expression in breast cancer, submitted).
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Survival rates of all patients were calculated by the
method of Kaplan and Meier. Data on breast cancer-
specific mortality was obtained from Finnish Cancer
Registry. Up to 20-year follow-up was available for this
patient cohort (cancers diagnosed between 1988 and
1992). The immunohistochemical staining for Ki-67 was
carried out as described above, except that PowerVision
+ kit (ImmunoVision, Springdale, AZ, USA) was used
for antibody detection and LabVision Autostainer (Lab-
Vision, Fremont, CA, USA) for staining automation.
Informed consent in very old retrospective patient
cohorts was deemed unnecessary, because the study was
approved by the local hospital ethics committee and the
National Supervisory Authority for Welfare Health.
Image acquisition
Digital images were captured using a Leica DM3000
microscope (Leica Microsystems, Wetzlar, Germany)
equipped with 10×, 20×, and 40× objective lenses, a 1×
phototube, and a Scion CFW-1612C digital color cam-
era (Scion Corporation, Frederick, MD, USA; 24-bit
color depth; resolution 1,600 × 1,200 pixels, pixel size
4.40 μm). The images were stored using an uncom-
pressed image file format (bitmap). For every imaging
session, an image from empty slide background area was
acquired (blankfield image), which was used to correct
image color balance and uneven illumination. Optimal
image brightness and contrast were determined by using
the Camera Adjustment Wizard, which was developed
as an incorporated function of ImmunoRatio. The Cam-
era Adjustment Wizard measures the brightness of the
blankfield image and performs a contrast analysis using
an image containing hematoxylin-stained cells. An opti-
mal brightness (mean gray intensity) of the blankfield
image is considered to be in the range of 200 to 250
(available range 0 to 255, black being 0). The contrast
analysis segments the hematoxylin-stained cells (fore-
ground) and analyzes their mean gray intensity, which is
then divided by the background mean gray intensity.
The contrast is considered to be optimal if the fore-
ground mean gray intensity is 50 to 80% of the back-
ground mean gray intensity.
Software development
ImmunoRatio was first developed as a plugin for the
ImageJ image analysis software (1.42 m) [16] using the
Java programming language [17]. In addition to built-in
ImageJ functions, the ImmunoRatio analysis algorithm
uses the Calculator Plus plugin [18] for blankfield cor-
rection, the Rolling Ball algorithm [19] for background
subtraction, the Color Deconvolution plugin [20] for
DAB and hematoxylin stain separation, the IsoData
algorithm [21] for adaptive thresholding, and the
Watershed algorithm [22] for nucleus segmentation.
The analysis algorithm steps are outlined in Figure 1. A
more detailed algorithm flowchart is available on our
website [15]. The ImmunoRatio plugin was embedded
into a Java servlet-based web application. The web appli-
cation was developed using Google Web Toolkit (1.7.0)
[23], Apache Commons FileUpload package (1.2.1) [24],
Apache Commons IO library (1.4) [25], Laboratory for
Optical and Computational Instrumentation Bio-
Formats package (4.1) [26], and Apache Tomcat servlet
container (6.0) [27].
Software calibration
From a pool of 100 immunohistochemically stained
slides, 50 were selected to be included in the training
set (25 stained for Ki-67, 13 for PR, and 12 for ER). The
labeling indexes (percentage of positively stained nuclei
by visual assessment) were evenly distributed, ranging
from 0 to 100%. From each training set slide, one image
representative for invasive carcinoma was acquired. Each
acquired image was analyzed visually by counting posi-
tively and negatively stained carcinoma cells on a com-
puter screen (a minimum of 500 cells total per image).
The percent of DAB-stained nuclei out of the total
nuclei (DAB- and hematoxylin-stained) was calculated
as the labeling index. This result was used as the gold
standard for ImmunoRatio calibration. The images were
then analyzed using non-calibrated ImmunoRatio, and
the results were compared with visual counting in a
scatter plot. Owing to the non-linear relation, a third
degree polynomial was fitted to the data. ImmunoRatio
was then calibrated by embedding the fitted polynomial
as a correction function into the analysis algorithm. To
validate the calibration and demonstrate the accuracy of
the analysis, the remaining 50 samples (25 stained for
Ki-67, 13 for PR, and 12 for ER) were used as a test set,
which was analyzed using calibrated ImmunoRatio. In
the final step of the validation, the minimum number of
images needed to be averaged from a typical tumor
sample (diameter 1 to 2 cm) was defined. From 10 sam-
ples, 12 images per sample representing central and per-
ipheral tumor areas were acquired using 20× objective.
Software testing
ImmunoRatio was initially developed and calibrated
using ER-, PR-, and Ki-67-stained slides, which were
considered optimal by an external quality assurance pro-
gram [3]. To simulate interlaboratory variability in stain-
ing results, the effect of suboptimal primary antibody
(Ki-67 MIB-1) dilution and hematoxylin counterstaining
intensity was studied. The robustness of ImmunoRatio
to variations in image acquisition settings was examined
by comparing the optical resolutions provided by 10×,
20×, and 40× microscope objectives, and by comparing
the analysis results obtained with six microscope
Tuominen et al. Breast Cancer Research 2010, 12:R56
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cameras: Scion CFW-1612C (Scion Corporation, Freder-
ick, MD, USA), Altra 20 (Olympus Corporation, Tokyo,
Japan), ColorView II (Olympus Corporation, Tokyo,
Japan), Leica DFC290 HD (Leica Microsystems, Wetzlar,
Germany), Mightex 3MP Color CMOS (Mightex Sys-
tems, Pleasanton, CA, USA), and Nikon DS-Fi1 (Nikon
Corporation, Tokyo, Japan). The primary output file for-
mat used in the acquisition was uncompressed (i.e., loss-
less). Images were also acquired using JPEG file format
(quality factors 10, 20, 40, 60, 80, and 100) to study the
suitability of lossy compression for ImmunoRatio analy-
sis. In addition, for each camera, the average diameter
Figure 1 A flowchart outlining the ImmunoRatio analysis algorithm. Step 1: A RGB color microscope image, an optional blankfield
correction image, and thresholding adjustment parameters are received as an input. Step 2: The blankfield image is used to correct uneven
illumination and color balance. If a blankfield image is not available, background subtraction is carried out using the Rolling ball algorithm [19].
Step 3: The Color Deconvolution plugin [20] is used to separate the stains into two eight-bit component images: diaminobenzidine (DAB) and
hematoxylin (H). Step 4: The components are processed with a mean filter and binarized using adaptive IsoData thresholding [21]. Component-
specific threshold adjustments are applied if defined via input parameters. Step 5: The components are processed with a median filter to
smooth the thresholding result. Nucleus segmentation is performed on both components by using the Watershed algorithm [22] and small
particles are discarded based on their size. For the H component, thin (fibroblastic) cells are identified and discarded using non-round particle
removal. Step 6: The H and DAB components are overlaid on the source image. The percentage of DAB-stained nuclear area out of the total
nuclear area (the labeling index) is calculated. An (optional) external calibration function is used to correct the ratio percentage. Step 7: The
result image consisting of image identification string, the analysis date, the result labeling index, the original image, and a pseudo-colored image
showing the staining components is created. A more detailed algorithm flowchart is available on our research group website [15].
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(pixels per μm) of a hematoxylin-stained nucleus was
measured. Linear regression was used to fit a first
degree polynomial to the data and the polynomial was
then embedded into the Scale Finder function of Immu-
noRatio. The Scale Finder assists the user in determin-
ing a rough scale estimate for the microscope setup, if
not known prior to analysis.
Results
ImmunoRatio software
We developed the ImmunoRatio image analysis soft-
ware, which segments the DAB- and hematoxylin-
stained nuclei areas from a microscope image, calculates
the labeling index (percent of DAB-stained area out of
the total nuclear area), and generates a pseudo-colored
result image matching the segmentation. An example
analysis output of a Ki-67 image is shown in Figure 2.
We first implemented ImmunoRatio as an open source
ImageJ plugin, which provides a graphical user interface,
as well as the possibility to use it with ImageJ macro
language. Multiple images from the same specimen can
be analyzed at once, resulting in a montage containing
all of the analyzed images. The plugin version enables a
direct link to image capture either by using the driver
plugins provided by the camera vendors or via the open
TWAIN protocol [28]. An open source version of the
plugin is available for free download [29].
Based on the plugin described above, we developed a
publicly available ImmunoRatio web application (see
screenshot in Figure 3). The web application resides in a
remote server and is accessed over the Internet with a
web browser, without any software downloads or instal-
lations. It supports all modern web browsers (e.g., Win-
dows Internet Explorer, Mozilla Firefox, Safari, and
Google Chrome) and all operating systems (e.g., Micro-
soft Windows, Linux distributions, and Mac OS). The
main features of the ImmunoRatio web application are
summarized in Table 1. The analysis is based on the
color deconvolution [12] for stain separation and adap-
tive IsoData algorithm [21] for thresholding. The analy-
sis can be made either to the whole image or to an
interactively defined region of interest (ROI). The analy-
sis adapts to various combinations of microscope objec-
tive lenses, phototubes, and camera resolutions by using
either an exact or an estimated image scale (pixels per
μm). The estimation can be performed using the Scale
Finder function. ImmunoRatio supports most existing
camera models and their output images, including JPEG,
JPEG2000, TIFF, BMP, and PNG. Optimal camera
brightness and contrast settings can be defined using
the assistance of the Camera Adjustment Wizard. Users
can calibrate the software with their own visually deter-
mined labeling index data and derive a suitable result
correction equation (a third degree polynomial). Users
can also fine-adjust the hematoxylin- and DAB-thresh-
olding parameters. For demonstrational analyses, Immu-
noRatio offers an introductory basic mode, which has a
simplified user interface with minimal required func-
tionality. ImmunoRatio web application is freely accessi-
ble on our research group website [15].
Calibration of ImmunoRatio
Although non-calibrated ImmunoRatio correlated well
with visual counting of DAB- and hematoxylin-stained
cell nuclei (r = 0.97), the results showed an obvious
non-linear relation (Figure 4a). Due to this non-linearity,
a third degree polynomial was fitted to the data and
used as a correction function to calibrate ImmunoRatio.
The analysis of the separate test set with calibrated
Figure 2 An example result of a Ki-67-stained image processed
with ImmunoRatio. The result image includes a sample identifier,
the analysis date, the labeling index (percentage of positively
stained nuclear area), the original image, and a pseudo-colored
image showing the segmented staining components.
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Figure 3 A screenshot of the ImmunoRatio web application. The Result window is shown as an insert in the right panel. The application is
publicly available on our jvsmicroscope.uta.fi website, where users can analyze their images freely.
Table 1 Main features of ImmunoRatio web application
Feature Description
Analytical principle Analyzes immunostained slides (ER, PR, Ki-67) using color deconvolution [12] for stain separation and
adaptive IsoData algorithm [21] for thresholding.
Users can analyze either the whole image or a region of interest.
Hardware and software
requirements
Runs within the web browser, requiring no additional program or plugin installations. Is compatible with all
modern web browsers and operating systems.
Compatibility with different
microscope setups
Adapts to various combinations of microscope objective lenses, phototubes, and camera resolutions.
Supports most existing camera models and image formats (JPEG, JPEG2000, TIFF, BMP, PNG).
Users can define optimal camera brightness and contrast settings with the Camera Adjustment Wizard.
Calibration Users can calibrate the application to match with their own visual cell counting data.
Usage modes Includes a basic mode for introductory analyses and a full-featured mode.
ER, estrogen receptor; PR, progesterone receptor.
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ImmunoRatio had a strong linear relation with visual
cell counting, showing a near-perfect correlation (r =
0.98; Figure 4b). The test set included two outlier obser-
vations, which were detected by visually inspecting the
pseudo-color result images. The first outlier had weak
DAB-staining intensity, making interpretation based on
visual counting difficult. The second outlier had too low
image contrast as demonstrated by using the Camera
Adjustment Wizard.
In the final step of the validation process, we defined
the minimum number of images needed to be captured
and analyzed in order to obtain a representative result
for the stained breast tumor slides. Using 20× micro-
scope objective, a sufficient number of images per sam-
ple for accurate ImmunoRatio analysis was determined
to be three (Figure 5). Averaging data from a higher
number of images was found to have a minimal impact
on the mean labeling index.
The effect of variability in staining and image acquisition
settings
The compatibility of ImmunoRatio with variable staining
and image acquisition settings is summarized in Table 2.
An optimally titrated primary antibody (1:100 for MIB-1
Ki-67) resulted in the best match with visual cell count-
ing. ImmunoRatio tolerated substantial deviations in the
antibody dilutions well. A usable antibody dilution was
1:50 to 1:200, because a four-times more diluted anti-
body (1:400) resulted in labeling indexes that were too
low, whereas using very concentrated antibody (1:25) led
to cytoplasmic background staining and labeling indexes
that were too high. Optimal hematoxylin
Figure 4 Scatter plots comparing labeling indexes defined by visual cell counting, non-calibrated ImmunoRatio, and calibrated
ImmunoRatio. (a) The calibration was made using a training set of 50 samples, of which 25 were stained for Ki-67, 13 for progesterone
receptor (PR), and 12 for estrogen receptor (ER). To achieve linear relation (dotted line), a correction function was defined by fitting a third
degree polynomial (solid black line) to the training set. (b) The calibration was validated by using a separate test set of 50 samples (25 stained
for Ki-67, 13 for PR, and 12 for ER). The validation test set included two outliers (marked as brown).
Figure 5 The mean labeling index of ImmunoRatio analysis as
a function of the number of images included in the averaged
result. Five samples stained for progesteron receptor (PR) and five
for Ki-67 were tested.
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counterstaining was found to be important. Weak coun-
terstaining caused the nuclear segmentation to fail,
whereas overly concentrated counterstaining led to false
segmentation of the cytoplasmic structures. Sample
images with optimal and non-optimal primary antibody
and hematoxylin counterstaining are presented in Figure
6.
Owing to the Scale Finder function, the results of
images acquired using 10×, 20×, and 40× objective
lenses (with a 1× phototube) were highly similar (data
not shown). The 20× objective was deemed to be opti-
mal, requiring at least three images per sample to be
averaged. The same results could be achieved by using
the 40× objective, but more images per sample needed
to be averaged. When using a 10× objective, consider-
ably more non-carcinomatous cells were often included
in the analysis. However, the ROI functionality of
ImmunoRatio can be used to circumvent this problem.
The differences in ImmunoRatio analysis results
between the tested camera models and repeated staining
batches were found to be small (data not shown).
Variation in image brightness and uneven illumination
can be accurately corrected by using the blankfield
image, captured using the same microscope and camera
settings. However, greatly underexposed images (blank-
field image mean gray intensity <200) as well as overly
overexposed images (blankfield image mean gray inten-
sity >250) may cause false labeling indexes. For accurate
nuclei segmentation, the image contrast must be rela-
tively high; the foreground mean gray intensity should be
50 to 80% of the background mean gray intensity. Users
can validate their image acquisition settings by using the
Camera Adjustment Wizard function of ImmunoRatio.
For the ImmunoRatio web application, it is advanta-
geous to use lossy image file formats (e.g., JPEG) to
minimize the data uploaded to the server for analysis.
Table 2 The compatibility of ImmunoRatio with variable staining and image acquisition settings
Immunostaining/image acquisition
feature
Compatibility with
ImmunoRatio
Comments
Primary antibody dilution
(defined for MIB-1 Ki-67)
too dilute (1:400) + too low labeling index (Figure 6a)
optimal (1:100) + + + best match with visual counting (Figure 6b)
too strong (1:25) + cytoplasmic background causing overly high labeling indexes (Figure 6c)
Hematoxylin counterstaining
weak - insufficient nuclear segmentation (Figure 6d)
optimal + + + best match with visual counting (Figure 6e)
strong + false segmentation of cytoplasmic structures (Figure 6f)
Microscope objective magnification
(using 1× phototube)
10× + non-carcinomatous cells often included*
20× + + + for accurate result, an average of three images per sample is
recommended
40× + + for accurate result, averaging several images per sample is recommended
Image brightness
underexposed (too dim) + mean gray intensity of the blankfield image <200
in optimal range + + + as guided by the Camera Adjustment Wizard of ImmunoRatio
overexposed (too bright) - mean gray intensity of the blankfield image >250
Image contrast
too low - foreground mean gray intensity over 85% of the background mean gray
intensity
in optimal range + + + as guided by the Camera Adjustment Wizard of ImmunoRatio
too high + foreground mean gray intensity under 50% of the background mean
gray intensity
Image compression
uncompressed (lossless) + + slow network transmission (slower overall analysis time)
JPEG, quality factor 50 to 100
(lossy)
+ + + optimal for ImmunoRatio
JPEG, quality factor <50 (lossy) - visible image artifacts
+ + + = optimally compatible, + + = compatible, + = compatible with possible chance of analytical errors, - = not compatible with ImmunoRatio.
* Region of interest function can be used to exclude unwanted tissue areas.
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We found that using lossy JPEG compression with qual-
ity factors 50 to 100 had no significant effect on the
accuracy of ImmunoRatio analysis results (data not
shown). This compression level allows a typical 5 mega-
byte uncompressed image to be compressed into 250
kilobytes (about 20:1 compression ratio), enabling rapid
image transfer with almost any network bandwidth.
Using very low JPEG quality factors (<50) can cause
image distortion and artifacts, making the analysis
unreliable.
Prognostic validation
As Ki-67 is used clinically as a prognostic parameter,
we confirmed the accuracy of ImmunoRatio analysis
Figure 6 The importance of optimal immunostaining conditions on the accuracy of ImmunoRatio analysis. The red lines outline the
nuclei and highlight the segmentation of (a to c) brown and (d to f) blue staining components. (a) Overly dilute primary antibody
concentration (Ki-67 MIB-1, 1:400) causes inadequate brown segmentation. (b) Optimal antibody dilution (1:100). (c) Overly strong antibody
concentration (1:25) results in excessive cytoplasmic staining and brown segmentation. (d) Overly dilute hematoxylin staining causes inadequate
blue segmentation. (e) Optimal hematoxylin dilution. (f) Overly strong hematoxylin causes excessive cytoplasmic staining and blue
segmentation.
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by examining patient survival in a retrospective analy-
sis of 123 breast cancer patients. As expected, based
on the literature [5], a strong prognostic correlation
was observed (Figure 7). Breast cancer-specific survival
of patients with high Ki-67 tumors was significantly
shorter than low Ki-67 during 20-year follow-up.
Labeling index values of 15%, 20%, and 25% were
tested as cut-off. Of those, 20% (the median in this
material), gave a hazard ratio (HR) of 2.2 (P = 0.01 by
log rank test). Cut-off values 15% and 25% yielded
similar results (HR = 2.1 and HR = 2.4, respectively,
data not shown).
Discussion
In this study, we described an image analysis applica-
tion, ImmunoRatio, which is an easy-to-use tool for
assessing ER, PR, and Ki-67 labeling indexes in
hematoxylin-counterstained tissue sections. Immu-
noRatio analysis is based on defining positively
stained pixel counts, which, according to our calibra-
tion data, correlates very well with cell nuclei enum-
erated visually. The calibration was performed using
a training set of 50 samples and validation using a
separate test set of 50 samples representing ER-, PR-,
and Ki-67-stained routine breast cancer specimens.
The correlation between manual and automated ana-
lysis was very high and matched, or exceeded, corre-
sponding results of other similar image analysis
software [30,31]. Due to the significant inter-observer
variability in visually defined labeling indexes, we
recommend that the users calibrate ImmunoRatio
with their own labeling index data, as demonstrated
in Figure 4 for the calibration training set. Once cali-
brated, ImmunoRatio can be easily integrated with
routine diagnostic work.
Another important aspect of calibration is to deter-
mine the optimal Ki-67 cutoff used for prognostic
assessment. We tested this with a retrospective analysis
of data from 123 primary breast cancer patients fol-
lowed up for 20 years. The Ki-67 labeling index 20%
(the median value in this material) gave a strong prog-
nostic discrimination (HR = 2.2). Although cut-off
values 15% and 25% yielded similar prognostication in
this patient material, we recommend each laboratory to
define their own cut-off value. We recommend using
the median value of the Ki-67 labeling index as cut-off.
This allows comparisons of different patient materials
and provides a reproducible classification of patients
according to Ki-67 labeling index.
In addition to accurate calibration, it is clear that for
routine use, an image analysis system must accept varia-
tion in staining intensity, in microscope setup, and in
image acquisition settings. We found up to eight-fold
range in primary antibody (Ki-67) dilution to be accep-
table for ImmunoRatio. However, when setting up an
optimal staining protocol, the users should pay close
attention to the hematoxylin counterstaining, which
must be bright and clearly separate the nuclei from the
Figure 7 Breast cancer-specific survival of 123 breast cancer patients according to the Ki-67 labeling index determined with
ImmunoRatio. The cut-off was set at median Ki-67 labeling index (20%). Tumors with a high labeling index were associated with poorer breast
cancer-specific survival during the follow up of 20 years (hazard ratio = 2.2, P = 0.01).
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background (see example Figure 6). In terms of optical
resolution, we recommend using a microscope setup
that roughly corresponds to 20× objective lens magnifi-
cation, 1× phototube, and a 1.5 megapixel camera.
Using this setup, a representative result from a typical
breast cancer tumor (diameter 1 to 2 cm) can be
obtained by averaging at least three images. Variation in
image brightness is well-tolerated owing to the blank-
field image correction. The Camera Adjustment Wizard
function is designed to help the user find the optimal
image brightness and contrast settings. A collection of
reference images with optimal staining and imaging set-
tings are presented on our website [15].
ImmunoRatio analysis is based on the color deconvo-
lution algorithm [12], which is one of the several exist-
ing alternatives for separating the staining components.
In addition to color deconvolution, stain separation and
nuclei segmentation have been performed using texture
analysis [32], cyan-magenta-yellow-black (CMYK) color
model [33], hue-saturation-intensity color model [34],
CIE 1976 L*u*v (CIELUV) color model [35], pattern
recognition [36], cluster analysis [37], and immunofluor-
escence with Automated QUantitative Analysis (AQUA)
[38]. However, the software applications described in
the above mentioned studies are mainly for research
purposes and they have not been released for public
use. Many of the methods may require considerable
work if employed in a routine clinical process. The
color deconvolution-based approach for separating two
stains is straightforward and fast, and is readily usable
for images captured with conventional microscope color
cameras. If more than two staining components are
used or the analysis requires accurate intensity-based
quantification, the AQUA method or multispectral ima-
ging would most likely be better alternatives [11].
ImmunoRatio was developed using ImageJ, which is a
public domain (i.e., completely free and open source)
image analysis software. However, a major obstacle in
adopting ImageJ, or any other image analysis software,
in clinical laboratories is usually the strict computer
security policy. The local system and network rules
usually prohibit users to download, install, and/or run
external applications. To address these constraints, we
released ImmunoRatio as a web application, which pro-
vides an easy-to-use web interface, requires no software
downloads or installations, and can be used in highly
restricted environments.
Conclusions
To the best of our knowledge, ImmunoRatio is the first
ready-to-use web application for analyzing nuclear
immunostains (e.g., ER, PR, and Ki-67). We want to
point out that ImmunoRatio is meant to be used as a
diagnostic aid by personnel trained to score
immunostained breast cancer slides. Furthermore, the
analysis results should always be interpreted together
with the pseudo-colored images and the original sample
slides. ImmunoRatio has already been used in the
authors’ laboratory for more than 1,000 cases and tested
by several collaborators. The application is open to free
public access on our research group website [15]. Com-
plementary software for analyzing cell membrane stain-
ing (e.g., HER-2) is currently being developed.
Abbreviations
AQUA: automated quantitative analysis; CIELUV: CIE 1976 L*u*v; CMYK: cyan-
magenta-yellow-black; DAB: diaminobenzidine; ER: estrogen receptor; HR:
hazard ratio; PBS: phosphate-buffered saline; PR: progesterone receptor; ROI:
region of interest.
Acknowledgements
This study was financially supported by the Finnish Cancer Foundation, the
Sigrid Juselius Foundation, the Tampere University Hospital, and the
Seinäjoki Central Hospital (governmental EVO grant). The authors wish to
thank laboratory technicians Sari Toivola, Kristiina Ryömä, Ritva Kujala, Helvi
Salmela, and Pirjo Pekkala for assisting in sample preparation and
immunostaining.
Author details
1Institute of Medical Technology, University of Tampere, Biokatu 6, 33014
Tampere, Finland. 2Department of Pathology, Seinäjoki Central Hospital,
Hanneksenrinne 7, 60220 Seinäjoki, Finland.
Authors’ contributions
VJT carried out the software design and implementation, prepared the
manuscript, and participated in the study design. SR performed the
immunohistochemistry and the software calibration. AV contributed to the
software design. MJ supervised the immunohistochemistry and the
calibration processes. JI was responsible for the study design and
coordination, and helped to draft the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 9 March 2010 Revised: 9 June 2010 Accepted: 27 July 2010
Published: 27 July 2010
References
1. Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ,
Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P,
Schnitt SJ, Wolff AC: NCCN Task Force Report: Estrogen Receptor and
Progesterone Receptor Testing in Breast Cancer by
Immunohistochemistry. J Natl Compr Canc Netw 2009, 7:S1-S21, quiz S22-
23.
2. United Kingdom National External Quality Assessment Service (UK
NEQAS). [http://www.ukneqas.org.uk/].
3. Nordic immunohistochemical Quality Control (NordiQC). [http://www.
nordiqc.org/].
4. de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V,
Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M: Ki-67 as
prognostic marker in early breast cancer: a meta-analysis of published
studies involving 12,155 patients. Br J Cancer 2007, 96:1504-1513.
5. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P: Proliferation markers and
survival in early breast cancer: a systematic review and meta-analysis of
85 studies in 32,825 patients. Breast 2008, 17:323-334.
6. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ, Panel
members: Thresholds for therapies: highlights of the St Gallen
International Expert Consensus on the primary therapy of early breast
cancer 2009. Ann Oncol 2009, 20:1319-1329.
Tuominen et al. Breast Cancer Research 2010, 12:R56
http://breast-cancer-research.com/content/12/4/R56
Page 11 of 12
7. Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by
immunohistochemistry is superior to the ligand-binding assay for
predicting response to adjuvant endocrine therapy in breast cancer. J
Clin Oncol 1999, 17:1474-1481.
8. Shousha S: Oestrogen receptor status of breast carcinoma: Allred/H
score conversion table. Histopathology 2008, 53:346-347.
9. Rüdiger T, Höfler H, Kreipe HH, Nizze H, Pfeifer U, Stein H, Dallenbach FE,
Fischer HP, Mengel M, von Wasielewski R, Müller-Hermelink HK: Quality
assurance in immunohistochemistry: results of an interlaboratory trial
involving 172 pathologists. Am J Surg Pathol 2002, 26:873-882.
10. Walker RA: Quantification of immunohistochemistry - issues concerning
methods, utility and semiquantitative assessment I. Histopathology 2006,
49:406-410.
11. Taylor C, Levenson R: Quantification of immunohistochemistry - issues
concerning methods, utility and semiquantitative assessment II.
Histopathology 2006, 49:411-424.
12. Ruifrok AC, Johnston DA: Quantification of histochemical staining by
color deconvolution. Anal Quant Cytol Histol 2001, 23:291-299.
13. van der Loos CM: Multiple immunoenzyme staining: methods and
visualizations for the observation with spectral imaging. J Histochem
Cytochem 2008, 56:313-328.
14. Rojo MG, Bueno G, Slodkowska J: Review of imaging solutions for
integrated quantitative immunohistochemistry in the Pathology daily
practice. Folia Histochem Cytobiol 2009, 47:349-354.
15. ImmunoRatio web application. [http://jvsmicroscope.uta.fi/immunoratio/].
16. ImageJ image analysis software. [http://rsb.info.nih.gov/ij/].
17. Java programming language. [http://java.sun.com/].
18. Calculator Plus ImageJ plugin. [http://rsbweb.nih.gov/ij/plugins/calculator-
plus.html].
19. Sternberg SR: Biomedical Image Processing. IEEE Computer 1983, 16:22-34.
20. Colour Deconvolution ImageJ plugin. [http://www.dentistry.bham.ac.uk/
landinig/software/cdeconv/cdeconv.html].
21. Ridler TW, Calvard S: Picture thresholding using an iterative selection
method. IEEE Trans Systems Man and Cybernetics 1978, 8:630-632.
22. Beucher S, Meyer F: The morphological approach to segmentation: The
watershed transformation. Mathematical Morphology in Image Processing
New York: Marcel DekkerDougherty ER , 1 1993, 433-481.
23. Google Web Toolkit. [http://code.google.com/webtoolkit/].
24. Apache Commons FileUpload library. [http://commons.apache.org/
fileupload/].
25. Apache Commons IO library. [http://commons.apache.org/io/].
26. The Laboratory for Optical and Computational Instrumentation (LOCI)
Bio-Formats library. [http://www.loci.wisc.edu/software/bio-formats/].
27. Apache Tomcat Java servlet container. [http://tomcat.apache.org/].
28. The TWAIN standard specification. [http://www.twain.org/].
29. ImmunoRatio ImageJ plugin. [http://jvsmicroscope.uta.fi/immunoratio-
plugin/].
30. Mofidi R, Walsh R, Ridgway PF: Objective measurement of breast cancer
oestrogen receptor status through digital image analysis. Eur J Surg
Oncol 2003, 29:20-24.
31. Faratian D, Kay C, Robson T, Campbell FM, Grant M, Rea D, Bartlett JM:
Automated image analysis for high-throughput quantitative detection of
ER and PR expression levels in large-scale clinical studies: the TEAM Trial
Experience. Histopathology 2009, 55:587-593.
32. Kostopoulos S, Cavouras D, Daskalakis A, Bougioukos P, Georgiadis P,
Kagadis GC, Kalatzis I, Ravazoula P, Nikiforidis G: Colour-texture based
image analysis method for assessing the hormone receptors status in
breast tissue sections. Conf Proc IEEE Eng Med Biol Soc 2007,
2007:4985-4988.
33. Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, Tsao MS, Ho J,
Hedley DW: Quantitative image analysis of immunohistochemical stains
using a CMYK color model. Diagn Pathol 2007, 2:8.
34. Ruifrok AC, Katz RL, Johnston DA: Comparison of quantification of
histochemical staining by hue-saturation-intensity (HSI) transformation
and color-deconvolution. Appl Immunohistochem Mol Morphol 2003,
11:85-91.
35. Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, Landberg G,
Duffy MJ, Jirstrom K, Gallagher WM: Novel image analysis approach for
quantifying expression of nuclear proteins assessed by
immunohistochemistry: application to measurement of oestrogen and
progesterone receptor levels in breast cancer. Breast Cancer Res 2008, 10:
R89.
36. Kostopoulos S, Cavouras D, Daskalakis A, Kagadis GC, Kalatzis I, Georgiadis P,
Ravazoula P, Nikiforidis G: Cascade pattern recognition structure for
improving quantitative assessment of estrogen receptor status in breast
tissue carcinomas. Anal Quant Cytol Histol 2008, 30:218-225.
37. Gustavson MD, Bourke-Martin B, Reilly DM, Cregger M, Williams C,
Tedeschi G, Pinard R, Christiansen J: Development of an unsupervised
pixel-based clustering algorithm for compartmentalization of
immunohistochemical expression using Automated QUantitative
Analysis. Appl Immunohistochem Mol Morphol 2009, 17:329-337.
38. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and
quantification of protein expression in tissue microarrays. Nat Med 2002,
8:1323-1327.
doi:10.1186/bcr2615
Cite this article as: Tuominen et al.: ImmunoRatio: a publicly available
web application for quantitative image analysis of estrogen receptor
(ER), progesterone receptor (PR), and Ki-67. Breast Cancer Research 2010
12:R56.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tuominen et al. Breast Cancer Research 2010, 12:R56
http://breast-cancer-research.com/content/12/4/R56
Page 12 of 12
